Large vaccine trials that are extensive both in size and scope tax the resources of sponsors and contract research organizations (CROs), particularly when the trials seek to compress a process that ordinarily takes years. Rapid but safe implementation of these vaccine studies’ new protocols is pushing trial design to the limit.
Leaders of 23 countries and the World Health Organization on March 30 backed an idea to create an international treaty that would help deal with future health emergencies like the coronavirus pandemic by tightening rules on sharing information.
A special fund for vaccine research that was set aside by the U.S. Department of Health and Human Services in 2010 has been misused to pay for unrelated expenses, a government report shows.
What will top the agenda of new U.S. FDA Commissioner Dr. Stephen Hahn?
Massachusetts imposed a four-month ban on sales of all vaping products, amid what officials called a national public health emergency that so far has been linked to nine deaths.
Researchers at The Scripps Research Institute in Florida published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.
New York City Mayor Bill de Blasio declared a public health emergency in parts of Brooklyn in response to a measles outbreak, requiring unvaccinated people living in the affected areas to get the vaccine or face fines.
The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm’s lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy’s Laboratories Ltd.
Eight medical device makers – including a startup that uses virtual reality to treat chronic pain – topped an innovation contest aimed at addressing the opioid crisis, the U.S. FDA said.
Insys Therapeutics Inc.’s legal woes deepened as New York’s attorney general filed a lawsuit seeking at least $75 million from the company.